Open AccessMANAGEMENT OF RETINAL PIGMENT EPITHELIUM TEAR DURING ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
Author(s) -
Paul Mitchell,
Francisco Rodríguez,
Antonia M. Joussen,
Adrian Koh,
Nicole Eter,
David T. Wong,
JeanFrançois Korobelnik,
Annabelle A. Okada
Publication year - 2020
Publication title -
retina
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.24
H-Index - 120
eISSN - 1539-2864
pISSN - 0275-004X
DOI - 10.1097/iae.0000000000003083
Subject(s) - medicine , retinal pigment epithelium , ranibizumab , ophthalmology , fundus photography , fluorescein angiography , fundus (uterus) , vascular endothelial growth factor , macular degeneration , optical coherence tomography , artificial tears , retinal , surgery , bevacizumab , vegf receptors , chemotherapy
This article aims to review current evidence on the development, diagnosis, and management of retinal pigment epithelium (RPE) tear during anti-vascular endothelial growth factor (VEGF) therapy.